Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flupentixol 1mg tablets
0403040F0AAABAB
|
Flupentixol hydrochloride (Antidepressant) | Flupentixol hydrochloride | Central Nervous System | 17,451 |
|
Flupentixol 500microgram tablets
0403040F0AAAAAA
|
Flupentixol hydrochloride (Antidepressant) | Flupentixol hydrochloride | Central Nervous System | 14,240 |
|
Flupentixol 3mg tablets
0402010H0AAAAAA
|
Flupentixol hydrochloride (Antipsychotic) | Flupentixol hydrochloride | Central Nervous System | 11,232 |
|
Fluanxol 500microgram tablets
0403040F0BBAAAA
|
Fluanxol | Flupentixol hydrochloride | Central Nervous System | 2,140 |
|
Fluanxol 1mg tablets
0403040F0BBABAB
|
Fluanxol | Flupentixol hydrochloride | Central Nervous System | 1,375 |
|
Depixol 3mg tablets
0402010H0BBAAAA
|
Depixol (Systemic) | Flupentixol hydrochloride | Central Nervous System | 1,095 |
|
Flupentixol 1mg/5ml oral solution
0403040F0AAAGAG
|
Flupentixol hydrochloride (Antidepressant) | Flupentixol hydrochloride | Central Nervous System | No data available |
|
Flupentixol 500micrograms/5ml oral liquid
0403040F0AAAFAF
|
Flupentixol hydrochloride (Antidepressant) | Flupentixol hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.